 |
|
|
| |
COSMOS Study: SVR4 results of a once daily regimen of simeprevir (TMC435) plus sofosbuvir (GS-7977) with or without ribavirin in HCV genotype 1 null responders
|
| |
| |
Reported by Jules Levin
CROI 2013 March 3-6
E Lawitz,1 R Ghalib,2 M Rodriguez-Torres,3 Z Younossi,4 A Corregidor,5
I Jacobson,6 K Callewaert,7 W Symonds,8 G Picchio,9 K Lindsay9
1The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA. 2The Liver Institute, Dallas, TX, USA. 3Fundacion de Investigacion, San Juan, Puerto Rico, USA. 4Inova Fairfax Hospital, Falls Church, VA, USA. 5Borland-Groover Clinic, Jacksonville, FL, USA. 6Weill Cornell Medical College, New York, NY, USA.7Janssen Research and Development, Beerse, Belgium.8Gilead Sciences, Inc., Foster City, CA, USA.9Janssen Research and Development LLC, Titusville, NJ, USA
|
| |
|
|
|
|
|
